BridgeBio Pharma, Inc. (BBIO) Current Reports & Earnings Releases
Upcoming
- 2026-10-28 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-17 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-08-10 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-22 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-07-02 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-26 | 8-K | Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-05-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-13 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-08 | 8-K | Material Agreement, Termination of Agreement, Financial Statements & Exhibits | SEC |
| 2026-05-07 | 8-K | Results of Operations, Other Events | SEC |
| 2026-03-30 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-02-24 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-12 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-21 | 8-K | Material Agreement, Direct Financial Obligation, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-12 | 8-K | Results of Operations, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-29 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-29 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-27 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-08-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-07-02 | 8-K | Material Agreement, Direct Financial Obligation | SEC |
| 2025-06-23 | 8-K | Item 3.03, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2025-04-29 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-17 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-28 | 8-K | Material Agreement, Termination of Agreement, Direct Financial Obligation, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-02-20 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-01-13 | 8-K | Results of Operations, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-25 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-09-11 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-21 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-08-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-07-23 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-06-24 | 8-K | Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2024-06-06 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-02 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-03-06 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-04 | 8-K | Material Agreement | SEC |
| 2024-02-22 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-01-18 | 8-K | Material Agreement, Termination of Agreement, Direct Financial Obligation | SEC |
| 2024-01-08 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.